click below
click below
Normal Size Small Size show me how
BDK Quiz 5
| Pharmacologic Category | Generic Name | Brand Name | Classification | Common Indications | Essential Knowledge |
|---|---|---|---|---|---|
| Mineralocorticoid receptor antagonist (MRA) | spironolactone | Aldactone | HTN, HF, ascites | Key Side Effects: gynecomastia, hyperkalemia, hypotension | |
| Loop diuretic | furosemide | Lasix | Volume overload | Key Side Effects: hypokalemia, hypomagnesemia, hyponatremia, hypotension US Boxed Warnings: fluid and electrolyte loss | |
| Loop diuretic | torsemide | Soaanz | Volume overload | Key Side Effects: hypokalemia, hypomagnesemia, hyponatremia, hypotension | |
| Beta1-selective beta-blocker | atenolol | Tenormin | AF (rate control), CAD, HTN | Key Side Effects: bradycardia, hypotension US Boxed Warnings: avoid abrupt discontinuation Other Notes: masks symptoms of hypoglycemia | |
| Beta1-selective beta-blocker | metoprolol tartrate (PO, IV) | Lopressor | AF (rate control), CAD, HTN | Key Side Effects: bradycardia, hypotension US Boxed Warnings: avoid abrupt discontinuation Other Notes: masks symptoms of hypoglycemia | |
| Beta1-selective beta-blocker | metoprolol succinate (PO) | Toprol-XL | HF, AF (rate control), CAD, HTN | Key Side Effects: bradycardia, hypotension Other Notes: masks symptoms of hypoglycemia | |
| Beta1-selective beta-blocker | nebivolol (PO) | Bystolic | HTN | Key Side Effects: bradycardia, hypotension Other Notes: masks symptoms of hypoglycemia | |
| Beta1-selective beta-blocker | esmolol (IV) | Brevibloc | HTN, AF (rate control), hypertensive emergency | Key Side Effects: bradycardia, hypotension Other Notes: masks symptoms of hypoglycemia; CI with pulmonary hypertension | |
| Non-selective beta-blocker and alpha1 blocker | carvedilol (PO) | Coreg, Coreg CR | HF, AF (rate control), CAD, HTN | Key Side Effects: bradycardia, hypotension Other Notes: masks symptoms of hypoglycemia | |
| Non-selective beta-blocker and alpha1 blocker | labetalol (PO, IV) | Trandate | PO: HTN IV: hypertensive crisis | Key Side Effects: bradycardia, hypotension Other Notes: masks symptoms of hypoglycemia | |
| Non-selective beta-blocker | propranolol (PO) | Inderal LA, Inderal XL | HTN, CAD, migraine prophylaxis | Key Side Effects: bradycardia, hypotension Other Notes: masks symptoms of hypoglycemia | |
| Alpha2 agonist | clonidine (PO, transdermal) | PO: Catapres, Transdermal: Catapres-TTS | HTN, ADHD | Key Side Effects: xerostomia, drowsiness, contact dermatitis (transdermal), hypotension US Boxed Warnings: avoid epidural use Other Notes: do not discontinue abruptly; taper to reduce rebound HTN | |
| Direct arterial vasodilator | hydralazine (PO, IV) | Apresoline | HTN | Key Side Effects: hypotension, drug-induced lupus-like syndrome Other Notes: CI in CAD | |
| Beta1, beta2, and alpha1 agonist | epinephrine (IV, IM, SQ) | Adrenalin, EpiPen | Advanced cardiac life support, shock, anaphylaxis, bradycardia | Key Side Effects: tachyarrhythmias, peripheral ischemia, hyperglycemia | |
| Alpha1 agonist (predominantly), beta1 and beta2 agonist | norepinephrine (IV) | Levophed | Shock | Key Side Effects: tachyarrhythmias, peripheral ischemia US Boxed Warning: extravasation (central line administration preferred) | |
| Anticoagulant, direct thrombin inhibitor | dabigatran (PO) | Pradaxa | AF (stroke prevention), VTE | Key Side Effects: bleeding, dyspepsia US Boxed Warnings: premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patients undergoing spinal puncture Other Notes: swallow whole; dispense and store in original packaging; discard 4 months after opening | |
| Anticoagulant, factor Xa inhibitor | apixaban (PO) | Eliquis | AF (stroke prevention), VTE | Key Side Effects: bleeding US Boxed Warnings: premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patient undergoing spinal puncture | |
| Anticoagulant, factor Xa inhibitor | rivaroxaban (PO) | Xarelto | AF (stroke prevention), VTE, PAD | Key Side Effects: bleeding US Boxed Warnings: premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patient undergoing spinal puncture | |
| Anticoagulant, vitamin K antagonist | warfarin (PO) | Coumadin, Jantoven | AF (stroke prevention), VTE | Key Side Effects: bleeding, skin necrosis US Boxed Warnings: bleeding risk Other Notes: narrow therapeutic index drug (toxicity may occur at concentrations close to therapeutic range; therapeutic monitoring recommended with INR) Other Notes: dose dependent tablet colors; consistent vitamin K intake recommended; many drug interactions | |
| Anticoagulant, low molecular weight heparin | enoxaparin (SQ) | Lovenox | ACS, VTE | Key Side Effects: bleeding, HIT US Boxed Warnings: increased risk of epidural or spinal hematoma in patients undergoing spinal puncture Other Notes: do not expel air bubble from syringe prior to injection | |
| Anticoagulant | heparin (IV, SQ) | --- | ACS, VTE | Key Side Effects: bleeding, hyperkalemia (chronic use), HIT | |
| Antiplatelet agent | clopidogrel (PO) | Plavix | ACS, CAD, stroke | Key Side Effects: bleeding US Boxed Warnings: diminished effectiveness in poor metabolizers | |
| Antiplatelet agent | ticagrelor (PO) | Brilinta | ACS | Key Side Effects: bleeding, dyspnea US Boxed Warnings: significant, sometimes fatal bleeding; do not exceed aspirin >100 mg daily due to reduced ticagrelor effectiveness | |
| Antiplatelet agent | aspirin (PO) | Bayer, Bufferin, Ecotrin | OTC | ACS, stable angina, pain, stroke | Key Side Effects: dyspepsia, heartburn, bleeding Other Notes: CI in NSAID or salicylate allergy, children and teenagers with viral infection (due to Reye’s syndrome), can cause tinnitus in salicylate overdose |
| Vasodilator | nitroglycerin (SL) | Nitrostat | ACS, stable angina | Key Side Effects: headache, flushing, syncope, dizziness Other Notes: do not use with PDE-5 Inhibitors; tachyphylaxis (tolerance/ ↓ effectiveness); can aggravate angina causes by hypertrophic cardiomyopathy | |
| Fibrinolytic | alteplase (intracatheter, IV) | Intracatheter: Cathflo Activase, IV: Activase | Intracatheter: catheter clearance IV: STEMI, acute ischemic stroke, PE | Key Side Effects: bleeding Other Notes: CI in patients with severe uncontrolled HTN | |
| Antiarrhythmic | amiodarone (PO, IV) | Pacerone, Nexterone | AF (rhythm control), ventricular fibrillation, ventricular tachycardia | Key Side Effects: hypothyroidism, hyperthyroidism, pulmonary toxicity, hepatotoxicity, epithelial keratopathy, photosensitivity US Boxed Warnings: intended only for life-threatening arrhythmias; pulmonary toxicity, hepatotoxicity; proarrhythmic Other Notes: many drug interactions | |
| Cholesterol absorption inhibitor | ezetimibe (PO) | Zetia | Dyslipidemia | Key Side Effects: myalgias, diarrhea | |
| Fibric acid derivative | fenofibrate (PO) | Tricor, Trilipix | Hypertriglyceridemia | Key Side Effects: dyspepsia, myopathy/rhabdomyolysis, elevated hepatic transaminases | |
| Fibric acid derivative | gemfibrozil (PO) | Lopid | Hypertriglyceridemia | Key Side Effects: dyspepsia, myopathy/rhabdomyolysis, elevated hepatic transaminases | |
| HMG-CoA reductase inhibitor | atorvastatin (PO) | Lipitor | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding | |
| HMG-CoA reductase inhibitor | lovastatin (PO) | Altoprev | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding | |
| HMG-CoA reductase inhibitor | pravastatin (PO) | Pravachol | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding | |
| HMG-CoA reductase inhibitor | rosuvastatin (PO) | Crestor | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding | |
| HMG-CoA reductase inhibitor | simvastatin (PO) | Zocor | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding | |
| Omega-3 fatty acids | omega-3 ethyl esters (PO) | Lovaza | OTC: various omega-3 formulations Rx: Lovaza & Vascepa | Hypertriglyceridemia | Key Side Effects: dyspepsia, eructation, fishy aftertaste Other Notes: can prolong bleeding time when used with other medication that can increase bleeding risk, use caution with fish/shellfish allergy |
| Omega-3 fatty acids | icosapent ethyl (PO) | Vascepa | OTC: various omega-3 formulations Rx: Lovaza & Vascepa | Hypertriglyceridemia | Key Side Effects: eructation, arthralgia Other Notes: can prolong bleeding time when used with other medication that can increase bleeding risk, use caution with fish/shellfish allergy |